BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 37253389)

  • 21.
    McTiernan N; Darbakk C; Ree R; Arnesen T
    Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33255974
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluating possible maternal effect lethality and genetic background effects in Naa10 knockout mice.
    Lyon GJ; Longo J; Garcia A; Inusa F; Marchi E; Shi D; Dörfel M; Arnesen T; Aldabe R; Lyons S; Nashat MA; Bolton D
    PLoS One; 2024; 19(5):e0301328. PubMed ID: 38713657
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metagenomic characterization of lysine acetyltransferases in human cancer and their association with clinicopathologic features.
    Jiang Y; Guo X; Liu L; Rode S; Wang R; Liu H; Yang ZQ
    Cancer Sci; 2020 May; 111(5):1829-1839. PubMed ID: 32162442
    [TBL] [Abstract][Full Text] [Related]  

  • 24. DNA methylation signatures for 2016 WHO classification subtypes of diffuse gliomas.
    Paul Y; Mondal B; Patil V; Somasundaram K
    Clin Epigenetics; 2017; 9():32. PubMed ID: 28392842
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expanding the phenotypic spectrum of NAA10-related neurodevelopmental syndrome and NAA15-related neurodevelopmental syndrome.
    Lyon GJ; Vedaie M; Beisheim T; Park A; Marchi E; Gottlieb L; Hsieh TC; Klinkhammer H; Sandomirsky K; Cheng H; Starr LJ; Preddy I; Tseng M; Li Q; Hu Y; Wang K; Carvalho A; Martinez F; Caro-Llopis A; Gavin M; Amble K; Krawitz P; Marmorstein R; Herr-Israel E
    Eur J Hum Genet; 2023 Jul; 31(7):824-833. PubMed ID: 37130971
    [TBL] [Abstract][Full Text] [Related]  

  • 26. ARD1/NAA10 acetylation in prostate cancer.
    Kuhns KJ; Zhang G; Wang Z; Liu W
    Exp Mol Med; 2018 Jul; 50(7):1-8. PubMed ID: 30054487
    [TBL] [Abstract][Full Text] [Related]  

  • 27. DKK3 expression is associated with immunosuppression and poor prognosis in glioblastoma, in contrast to lower-grade gliomas.
    Han MH; Baek JM; Min KW; Cheong JH; Ryu JI; Won YD; Kwon MJ; Koh SH
    BMC Neurol; 2023 May; 23(1):183. PubMed ID: 37149563
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phenotypic and biochemical analysis of an international cohort of individuals with variants in NAA10 and NAA15.
    Cheng H; Gottlieb L; Marchi E; Kleyner R; Bhardwaj P; Rope AF; Rosenheck S; Moutton S; Philippe C; Eyaid W; Alkuraya FS; Toribio J; Mena R; Prada CE; Stessman H; Bernier R; Wermuth M; Kauffmann B; Blaumeiser B; Kooy RF; Baralle D; Mancini GMS; Conway SJ; Xia F; Chen Z; Meng L; Mihajlovic L; Marmorstein R; Lyon GJ
    Hum Mol Genet; 2019 Sep; 28(17):2900-2919. PubMed ID: 31127942
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A splice donor mutation in NAA10 results in the dysregulation of the retinoic acid signalling pathway and causes Lenz microphthalmia syndrome.
    Esmailpour T; Riazifar H; Liu L; Donkervoort S; Huang VH; Madaan S; Shoucri BM; Busch A; Wu J; Towbin A; Chadwick RB; Sequeira A; Vawter MP; Sun G; Johnston JJ; Biesecker LG; Kawaguchi R; Sun H; Kimonis V; Huang T
    J Med Genet; 2014 Mar; 51(3):185-96. PubMed ID: 24431331
    [TBL] [Abstract][Full Text] [Related]  

  • 30. SHOX2 is a Potent Independent Biomarker to Predict Survival of WHO Grade II-III Diffuse Gliomas.
    Zhang YA; Zhou Y; Luo X; Song K; Ma X; Sathe A; Girard L; Xiao G; Gazdar AF
    EBioMedicine; 2016 Nov; 13():80-89. PubMed ID: 27840009
    [TBL] [Abstract][Full Text] [Related]  

  • 31. N-α-acetyltransferase 10 protein promotes metastasis by stabilizing matrix metalloproteinase-2 protein in human osteosarcomas.
    Chien MH; Lee WJ; Yang YC; Tan P; Pan KF; Liu YC; Tsai HC; Hsu CH; Wen YC; Hsiao M; Hua KT
    Cancer Lett; 2018 Oct; 433():86-98. PubMed ID: 29960050
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serine Incorporator 2 (SERINC2) Expression Predicts an Unfavorable Prognosis of Low-Grade Glioma (LGG): Evidence from Bioinformatics Analysis.
    Qi C; Lei L; Hu J; Wang G; Liu J; Ou S
    J Mol Neurosci; 2020 Oct; 70(10):1521-1532. PubMed ID: 32642801
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Severe syndromic ID and skewed X-inactivation in a girl with NAA10 dysfunction and a novel heterozygous de novo NAA10 p.(His16Pro) variant - a case report.
    Bader I; McTiernan N; Darbakk C; Boltshauser E; Ree R; Ebner S; Mayr JA; Arnesen T
    BMC Med Genet; 2020 Jul; 21(1):153. PubMed ID: 32698785
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Integrative Analysis of Neuregulin Family Members-Related Tumor Microenvironment for Predicting the Prognosis in Gliomas.
    Zhao WJ; Ou GY; Lin WW
    Front Immunol; 2021; 12():682415. PubMed ID: 34054873
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Connective tissue growth factor as an unfavorable prognostic marker promotes the proliferation, migration, and invasion of gliomas.
    Song ZB; Yang HP; Xu AQ; Zhan ZM; Song Y; Li ZY
    Chin Med J (Engl); 2020 Mar; 133(6):670-678. PubMed ID: 32197031
    [TBL] [Abstract][Full Text] [Related]  

  • 36. NAA10 p.(N101K) disrupts N-terminal acetyltransferase complex NatA and is associated with developmental delay and hemihypertrophy.
    McTiernan N; Gill H; Prada CE; Pachajoa H; Lores J; ; Arnesen T
    Eur J Hum Genet; 2021 Feb; 29(2):280-288. PubMed ID: 32973342
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Unc-5 homolog B (UNC5B) is one of the key downstream targets of N-α-Acetyltransferase 10 (Naa10).
    Xu H; Han Y; Liu B; Li R
    Sci Rep; 2016 Dec; 6():38508. PubMed ID: 27910960
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Methylation profiling identifies 2 groups of gliomas according to their tumorigenesis.
    Laffaire J; Everhard S; Idbaih A; Crinière E; Marie Y; de Reyniès A; Schiappa R; Mokhtari K; Hoang-Xuan K; Sanson M; Delattre JY; Thillet J; Ducray F
    Neuro Oncol; 2011 Jan; 13(1):84-98. PubMed ID: 20926426
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pyroptosis relates to tumor microenvironment remodeling and prognosis: A pan-cancer perspective.
    Khan M; Ai M; Du K; Song J; Wang B; Lin J; Ren A; Chen C; Huang Z; Qiu W; Zhang J; Tian Y; Yuan Y
    Front Immunol; 2022; 13():1062225. PubMed ID: 36605187
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    Johnston JJ; Williamson KA; Chou CM; Sapp JC; Ansari M; Chapman HM; Cooper DN; Dabir T; Dudley JN; Holt RJ; Ragge NK; Schäffer AA; Sen SK; Slavotinek AM; FitzPatrick DR; Glaser TM; Stewart F; Black GC; Biesecker LG
    J Med Genet; 2019 Jul; 56(7):444-452. PubMed ID: 30842225
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.